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OBJECTIVES We aimed to ascertain whether triggered intravenous myocardial contrast echocardiography
(MCE) can predict functional recovery in patients with acute myocardial infarction (AMI)
and to determine the optimal triggering interval in this setting.
BACKGROUND Detection of myocardial viability early after AMI has both therapeutic and prognostic
implications. Myocardial contrast echocardiography using intracoronary injections of contrast
can detect viable myocardium, but there is little data on the use of recently developed
intravenous MCE techniques for this purpose.
METHODS Ninety-six patients with recent AMI (4.8 6 1.7 days) underwent echocardiography at
baseline and six months later or three months after revascularization to determine regional
function (score 1 5 normal to 3 5 akinetic). Myocardial contrast echocardiography was
performed at baseline using intravenous injections of Optison. Triggering intervals of 1:1
(early) and 1:10 (delayed) cardiac cycles were used. Segments were deemed viable if they
demonstrated homogeneous contrast opacification.
RESULTS Of 400 akinetic segments at baseline, 109 (27%) improved during the follow-up period, and
375 (94%) were adequately visualized with MCE, of which 59 (16%) were homogeneously
opacified by early and 125 (33%) by delayed MCE (negative predictive value for recovery of
contractile function 74% and 84%, positive predictive value 29% and 47%, respectively).
Independent predictors of functional recovery were delayed MCE (odds ratio [OR]: 4.0, p ,
0.001), revascularization (OR: 6.0, p , 0.001), and log creatine kinase (OR: 0.5, p 5 0.03).
However, the presence or absence of .90% stenosis of the infarct-related artery did not
influence the ability of triggered MCE to predict functional recovery.
CONCLUSIONS Intravenous delayed triggered MCE can independently detect myocardial viability early after
AMI. (J Am Coll Cardiol 2001;38:19–25) © 2001 by the American College of Cardiology
When regional myocardial blood flow is reduced distal to a
coronary stenosis, resting contractile function of the affected
myocardium may be down-regulated despite the presence of
persisting viability. It has been demonstrated in both in
animal models (1) and in patients (2) that myocardial
contrast echocardiography (MCE) can detect myocardial
viability, and this technique has been correlated with nuclear
perfusion (3), dobutamine echocardiography (4) and func-
tional improvement (2,5–9). The advent of intravenous
contrast agents has facilitated the more widespread use of
this technique. There is, however, little published data on
the use of MCE for the assessment of myocardial viability in
patients early after acute myocardial infarction (AMI).
Since contrast is destroyed by the ultrasound beam,
triggered imaging has been required to visualize the small
amounts of contrast present within the myocardium when
intravenous administration is used. Triggering allows time
for contrast to fill the region of interest before the next
imaging pulse and, thus, ameliorates the problems of con-
trast destruction. However, in areas with low resting blood
flow, triggering every cardiac cycle may not allow sufficient
time for contrast to fill the region of interest, and longer
triggering intervals may be required (10). We aimed to
determine whether triggered intravenous MCE can be used
clinically to predict functional recovery of dysynergic myo-
cardium early after AMI and to ascertain whether delayed
triggering improves myocardial opacification.
METHODS
Stable patients with documented AMI were included in this
study. Patients with postinfarct angina, persistent left ven-
tricular (LV) failure and significant ventricular arrhythmias
were excluded. All patients gave prior consent, and the study
was approved by the local ethical committee. Patients
underwent MCE during hospital admission but at least
three days after AMI. Patients were then followed up and
underwent resting echocardiography six months later or at
least three months after revascularization in those who
underwent such a procedure, whichever was later.
Echocardiography. Echocardiography was performed by
the same sonographer using tissue harmonic imaging with a
broad-band transducer (4-2 MHz) (HDI5000, ATL, Both-
ell, Washington). Standard apical and parasternal views
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were used. Four representative views were stored using a
digital capture system. Images from each echocardiography
study in each view were displayed side-by-side for subse-
quent wall motion analysis. Systolic wall thickening was
scored using the American Society of Echocardiography
16-segment LV model by two experienced observers who
were blinded to the clinical details of the patients. A three
point scale was used to score systolic wall thickening: 1 5
normal, 2 5 reduced, 3 5 absent. Disagreements were
resolved by consensus.
MCE. Myocardial contrast echocardiography was per-
formed using pulse inversion harmonic imaging (mechanical
index 0.9) after baseline wall motion images had been
captured. Slow boluses of 0.3 to 0.7 mls of Optison
(Mallinkrodt, St. Louis, Missouri) were injected intrave-
nously followed by a saline flush over 20 s, and single frame
images were captured using an electrocardiogram (ECG)
trigger set at end-systole. Images were captured every
cardiac cycle (early MCE) and then 5 and 10 (delayed
MCE) cardiac cycles after each injection of contrast in each
of the three standard apical views when attenuation was
confined to the left atrium, and, at the same time, a flow of
contrast was visible in the right ventricle. The focus was set
at the mitral valve level, but, if there was concern about a
possible apical defect, the focus was moved up toward the
apex. Further injections of contrast were used in nonstand-
ard apical views (e.g., bringing lateral wall into sector field)
if required to attempt to overcome localized areas of
attenuation. The studies were recorded on videotape and
analyzed after the completion of the study. The same
16-segment LV model was used, and MCE was scored
semiquantitatively using a three point scale: 1 5 homoge-
neous contrast opacification, 2 5 reduced or heterogeneous
contrast opacification, 3 5 no contrast opacification. Myo-
cardial contrast echocardiography was scored at each trig-
gering interval by two experienced observers who were
blinded to the clinical details of the patients and the
follow-up echocardiography. A contrast defect index was
calculated for each triggering interval by adding the contrast
scores of akinetic segments and dividing by the number of
akinetic segments.
Only segments that were akinetic at baseline were ana-
lyzed. In patients with prior infarction, only the segments
related to the area of recent infarction were analyzed. The
area of recent infarction was defined based on the admitting
ECG. Each segment was divided into one of two groups:
viable, if myocardial function recovered during follow-up, or
nonviable, if no improvement was seen. The viable group
was subdivided into segments that improved spontaneously
and those that improved after revascularization. Recovery of
function was defined as improvement of an akinetic segment
(score 5 3) to hypokinesia (score 5 2) or normality (score 5
1). A segment was defined as viable by contrast echocardi-
ography only if there was homogeneous contrast opacifica-
tion (score 5 1), and a score .1 was considered to represent
nonviability. This was determined for both early and de-
layed MCE. Contrast and follow-up echocardiography
results were then compared for each segment to determine
the ability of MCE to predict functional recovery early after
AMI.
Coronary angiography and revascularization. Coronary
angiography was not a requirement for entry into this study,
but many patients underwent this procedure on clinical
grounds. Coronary angiograms were analyzed by the clini-
cian managing the patient using a visual quantitative scoring
system as is standard practice in our institution. The
infarct-related area (IRA) was determined using the admis-
sion ECG to identify the site of AMI, and the most
significant stenosis of an artery supplying that territory was
used for analysis. The decision to proceed with coronary
revascularization was made on clinical grounds and not
based on the results of MCE. At our institution, revascu-
larization is performed for recurrent unstable angina, high-
risk exercise ECG, severe three-vessel coronary disease or
left main stem disease.
Statistics. All categorical variables are shown as propor-
tions. Continuous variables are shown as mean 6 standard
deviation except for those that are not normally distributed,
which are presented as medians with 95% confidence
intervals (CI). The median contrast defect index was calcu-
lated for each patient, and the Mann-Whitney U test was
used to compare those patients who did and those who did
not show recovery of function. The sensitivity, specificity,
positive predictive value (PPV) and negative predictive value
(NPV) for prediction of recovery of function on a segmental
basis were determined for both MCE variables. Sensitivities
and specificities were compared using McNemar’s test.
Univariate logistic regression analysis to predict recovery of
function on a segmental basis was performed for each
categorical and continuous variable. Positively skewed vari-
ables were log transformed for further analysis. Multiple
logistic regression analysis was then performed including all
variables using backwards elimination. For all logistic re-
gression analyses, robust Huber-White estimates of the
standard errors of the regression coefficients were calculated,
taking into account the fact that segments from the same
patient may not be independent. Finally, a single variable
Abbreviations and Acronyms
AMI 5 acute myocardial infarction
CI 5 confidence interval
CK 5 creatine kinase
CK-MB 5 creatine kinase isoenzyme
ECG 5 electrocardiogram
IRA 5 infarct-related artery
LV 5 left ventricle or left ventricular
MCE 5 myocardial contrast echocardiography
NPV 5 negative predictive value
OR 5 odds ratio
PPV 5 positive predictive value
PTCA 5 percutaneous transluminal coronary
angioplasty
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was generated to represent the three possible combinations
of contrast opacification for each segment from early and
delayed MCE (no contrast opacification, opacification with
delayed MCE only, opacification with early and delayed
MCE). Logistic regression was then performed using this as
the dependent variable and stenosis severity as the indepen-
dent variable. A p value of ,0.05 was considered significant.
All statistical analyses were performed using Stata Version 6.
RESULTS
Patients. Ninety-eight patients were included in the study.
Two patients suffered a further AMI before the final
echocardiography and were excluded from the analysis as a
consequence. Demographic details of the remaining 96
patients are shown in Table 1. Baseline echocardiography
and MCE were performed 4.8 6 1.7 days after the AMI.
Follow-up. Of 96 patients, 27 (28%) underwent revascu-
larization procedures (19 percutaneous transluminal coro-
nary angioplasty [PTCA], 8 coronary artery bypass graft) at
a median of 32 (CI: 4 to 335) days after the baseline study.
The final follow-up echocardiography was performed at a
mean of 147 (CI: 18 to 224) days after revascularization in
this group and 179 (CI: 27 to 361) days after the baseline
study in the entire cohort.
Echocardiography. Of a total of 1,536 myocardial seg-
ments, 421 (27%) were akinetic at baseline. Twenty-one of
these segments were excluded on the basis of prior remote
infarction, and 109 (27%) of the remaining 400 demon-
strated functional improvement during the course of the
study. Fifty-three (49%) of the segments that improved
occurred in patients who underwent revascularization, while
the rest improved spontaneously.
MCE. Adequate MCE was achieved in 1,429 (93%) seg-
ments overall and in 375 (94%) of the 400 akinetic segments
assessed for the study. Over half of the artefacts preventing
assessment of MCE occurred in the basal inferoposterior
(26%), lateral wall (7%) and the anterior wall (25%). Of the
akinetic segments in which contrast could be adequately
assessed, homogeneous contrast opacification was seen in 59
(16%) during early and 125 (33%) during delayed MCE.
The median contrast defect index was significantly higher
in segments that did not recover than it was in those that did
recover, for both early (1.61 [CI: 1.36 to 1.813] vs. 1.26 [CI:
1.19 to 1.46] p 5 0.04) and delayed triggering (1.52 [CI:
1.16 to 1.69] vs. 1.13 [CI: 1.04 to 1.25] p 5 0.003), and the
index was significantly (p , 0.001) higher at shorter
triggering intervals.
The overall PPV of early MCE for the prediction of
functional recovery was only 29% with an NPV of 74%. The
PPV improved to 47% with delayed MCE, and the NPV
increased to 84%. The PPV of delayed MCE for the
prediction of functional recovery was higher in patients who
were revascularized (78%) than it was in those who were not
(34%) (Table 2). The PPV of delayed MCE was similar for
inferior (44%) and anterior (51%) AMI, but the NPV was
higher in anterior AMI (89% vs. 65%). Figures 1 and 2
show respective examples of recovery of function and failure
of functional recovery correctly predicted by delayed MCE.
The univariate predictors of recovery of function were
homogeneous opacification by delayed MCE, revasculariza-
tion, non–Q-wave AMI, logCK and logCK-MB. The
chi-square and significance values are shown in Table 3.
Creatine kinase and creatine kinase isoenzyme were highly
correlated, so only one was included in the regression model
at any one time. The independent predictors of functional
Table 1. Demographics of the Study Cohort and Details of
Presenting Myocardial Infarction
Demographics:
Age (yr) 60 6 12
Men 68 (71%)
Diabetic 13 (14%)
Hypertension 35 (36%)
Smoker 44 (46%)
Ex-smoker 20 (21%)
Medical history:
History of IHD 14 (15%)
Previous MI 12 (13%)
CABG 1 (1%)
PTCA 1 (1%)
Acute MI:
ST-elevation 85 (89%)
Thrombolysis 69 (72%)
Q-waves 63 (66%)
Peak CK (IU/l) 2,066 6 1,844
Peak CK-MB (IU/l) 176 6 146
Electrocardiographic infarct site:
Anterior 41 (43%)
Lateral 5 (5%)
Inferior 47 (49%)
Posterior 3 (3%)
CABG 5 coronary artery bypass graft; CK 5 creatine kinase; CK-MB 5 creatine
kinase isoenzyme; IHD 5 ischemic heart disease; MI 5 myocardial infarction;
PTCA 5 percutaneous transluminal coronary angioplasty.
Table 2. Comparison of Sensitivities, Specificities, NPVs and PPVs for Prediction of Functional
Recovery on a Segmental Basis Using Early and Delayed Myocardial Contrast Echocardiography
All Patients Revascularized Nonrevascularized
Early Delayed Early Delayed Early Delayed
Sensitivity 17% 59%* 21% 62%* 13% 57%*
Specificity 85% 76%* 89% 85%† 84% 74%*
PPV 29% 47% 63% 78% 16% 34%
NPV 74% 84% 57% 72% 80% 88%
*p , 0.001; †p 5 NS.
NPV 5 negative predictive value; PPV 5 positive predictive value.
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recovery were revascularization (odds ratio [OR]: 6.0, 95%
CI: 1.8 to 19.9, p , 0.001), delayed MCE (OR: 4.0, 95%
CI: 1.9 to 8.7, p , 0.001) and logCK (OR: 0.5, 95% CI:
0.27 to 0.94, p 5 0.03).
Coronary angiography. Sixty-six patients (69%) under-
went coronary angiography during the follow-up period.
Twenty-four patients had occlusion of the IRA, and 25 had
a stenosis of at least 90%. Thus, of the patients whose
coronary anatomy was known, the majority (74%) had a
stenosis of at least 90% in the IRA. However, when entered
into the logistic regression model, the degree of stenosis of
the IRA was not a significant predictor of recovery of
function (p 5 0.9) or of the relationship between early and
delayed MCE (p 5 0.5).
DISCUSSION
This study demonstrates that intravenous MCE can predict
the potential for recovery of myocardial function early after
AMI. While hypokinetic myocardium retains some con-
tractile function and, thus, is always viable (and, therefore,
was not included in our analysis), akinetic myocardium may
be either necrotic or viable. Necrotic myocardium is char-
acterized by loss of membrane integrity, lack of glycolytic or
mitochondrial function and absence of contractile potential.
These factors can be identified as abnormalities at thallium-
201 perfusion imaging, positron emission tomography,
technetium-99m perfusion imaging and dobutamine stress
echocardiography, respectively. In addition, when tissue
becomes necrotic, the local capillary network becomes
thrombosed and occluded (11). Viable myocardium, on the
other hand, retains all of these functions, which are depen-
dent on the presence of an intact capillary network, but
contractile function may be down-regulated in some cir-
cumstances. Viable but akinetic myocardium may be sub-
tended by an open artery (“stunned”) (12,13) or by a stenotic
or occluded artery (“repetitively stunned” or “hibernating”).
Stunned myocardium typically occurs in the peri-infarct
zone because of an acute reduction in blood flow, which is
then partially or completely relieved before necrosis can
occur, and thus may be expected to recover spontaneously.
However, dysfunctional myocardium may fail to recover
despite the absence of necrosis when subjected to persis-
tently reduced flow (hibernating) or recurrent episodes of
insufficient flow (repetitively stunned), such as in the pres-
ence of a high-grade stenosis or collateral flow in the
presence of an occluded vessel. This down-regulation of
contractile function will recover only after the restoration of
normal blood supply by revascularization. Consequently, the
ability to detect dysfunctional, but viable, myocardium after
myocardial infarction has important prognostic and thera-
peutic implications.
Mechanism. Myocardial contrast echocardiography de-
tects contrast microbubbles at the capillary level within the
myocardium and, thus, has the potential to assess tissue
Figure 1. Four-chamber view showing an akinetic septum and apex (a) with absent contrast opacification in this region at short triggering intervals (b) but
homogeneous opacification with delayed triggering (c) and normal resting function six months later (d).
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viability (2). However, because the ultrasound beam used to
detect the microbubbles also destroys them at normal power
outputs (14), the lower the myocardial blood flow the longer
the time required to achieve peak video intensity (10).
Accordingly, since many patients after AMI have areas of
low resting blood flow, the presence of contrast micro-
bubbles, and, thus, viability, might be underestimated if
contrast destruction exceeds replenishment. By allowing an
increased time interval between imaging pulses, delayed
MCE may permit contrast to flow into such poorly perfused
areas without destruction and alleviate this problem (15).
This study demonstrates that delayed MCE significantly
improves the sensitivity for the detection of viability. Fur-
thermore, in this study, delayed MCE independently pre-
dicted recovery of myocardial function, while early MCE
did not.
However, when comparing early MCE with delayed
MCE, we were not able to demonstrate that the improved
predictive power of delayed MCE was related to the degree
of stenosis of the IRA. We believe this is because 74% of
patients in this study had IRA stenoses $90%, and only
three patients had ,75% stenoses. Indeed, it is probable
that delayed MCE was superior to early MCE in this study
specifically because of the high incidence of high-grade
stenoses and, thus, the high-frequency of areas of myocar-
dium with impaired resting blood flow. However, further
studies of patients with a broader range of IRA stenoses are
required to confirm this.
This theory, however, does not explain why some seg-
ments with “patent” (,90% stenosis) epicardial vessels
showed improved contrast opacification with delayed trig-
gering compared with early triggering. We propose two
possible alternative explanations for this finding. In the early
days after AMI, it is possible that, despite a patent epicardial
vessel, there has been thrombus and plaque embolization to
the distal vessels, causing sludging of arterioles and a
reduction of microvascular flow (“low reflow”) as assessed by
Figure 2. Four-chamber view showing an akinetic septum and apex (a) with no contrast opacification in this area with early (b) or delayed (c) triggered
imaging and failure of recovery of systolic function at follow-up (d).
Table 3. Chi-Square and Significance Values for Univariate
Predictors of Segmental Functional Recovery
Chi-square p Value
Age 0.1 .0.1
Gender 0.2 .0.1
Diabetes mellitus 0.0 .0.1
Hypertension 0.8 .0.1
Infarct territory 3.7 0.06
ST-elevation 0.0 .0.1
Thrombolysis 0.8 .0.1
Log (peak creatine kinase) 4.3 0.04
Log (peak CK-MB) 5.6 0.02
Q-wave infarct 5.3 0.02
Early MCE 0.1 .0.1
Delayed MCE 20.2 ,0.0001
Revascularization 6.0 0.01
CK-MB 5 creatine kinase isoenzyme; MCE 5 myocardial contrast echocardiogra-
phy.
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triggered MCE. Indeed, Brochet et al. (16) reported a group
of patients in whom contrast opacification was absent when
intracoronary contrast was given immediately after primary
PTCA in AMI, but it improved when the study was
performed nine days later. In that study, 34% of segments
with this improvement in contrast opacification demon-
strated functional recovery at six weeks compared with 7%
of segments with a sustained contrast defect (“no reflow”).
An alternative explanation for the lack of full contrast
opacification at 1:1 triggering is that, even with normal flow,
there might be insufficient time for contrast to fill the
ultrasound beam width.
Clinical implications. The most important clinical impli-
cation of these results is that, of all the clinical variables
studied, the presence of myocardial viability as detected by
delayed MCE was the best predictor of functional recovery.
Furthermore, delayed MCE has a high NPV for recovery of
function. This correlates well with studies using intracoro-
nary injections of contrast, which have shown that micro-
vascular integrity is a prerequisite for functional recovery
(4,5,9,17–20). In particular, the use of delayed MCE further
improves the NPV of this technique compared with early
MCE. The PPV of delayed MCE for the prediction of
functional recovery was, however, less striking. This, too, is
in keeping with other studies that have assessed the ability
of intracoronary MCE (9) and alternative perfusion imaging
modalities to predict functional recovery (8). However, in
patients who were revascularized, in whom maximal recov-
ery of hibernating myocardium would be anticipated, the
PPV of MCE was much higher (74%) than in patients who
did not undergo revascularization (34%), in whom any
hibernating myocardium would not be expected to recover.
Also, although the majority of functional recovery occurs in
the first few weeks after revascularization (9,19), improve-
ment can continue for up to six months or more, particularly
in patients with longstanding areas of hibernation (21). For
this reason, follow-up scans were performed at least three
months after the revascularization procedure was per-
formed. However, it is possible that if additional follow-up
had been performed, delayed functional recovery might have
been demonstrated, improving the PPV. Another explana-
tion for the lower PPV of contrast echocardiography for
detection of functional recovery is the fact that the suben-
docardium is responsible for 80% of systolic wall thickening
(22). Thus, in patients with subendocardial infarction,
resting wall thickening may remain absent despite consid-
erable subepicardial viability. On the other hand, these
viable areas may still be important for the prevention of
adverse remodeling even if they never contribute to resting
contractile function (23). In this context, a comparison of
MCE with techniques such as radionuclide imaging
(positron emission tomography or nuclear perfusion imag-
ing) or gadolinium-enhanced magnetic resonance imaging,
which also assess myocardial perfusion, might have resulted
in greater agreement.
Comparison with previous studies. Our results comple-
ment those of Lepper et al. (24) who demonstrated that
MCE using 1:1 triggering has the potential to identify
viable myocardium after AMI. This study was performed in
patients who had undergone acute PTCA and who, there-
fore, had patent IRA. It is, thus, likely that blood flow to
any viable myocardium would have been normal and,
therefore, that 1:1 triggering would be sufficient to demon-
strate myocardial perfusion. In our study population, how-
ever, thrombolysis was used, with the result that 74% of
patients had a severe stenosis (.90%) or occlusion of the
IRA, and, therefore, longer triggering intervals were re-
quired to achieve adequate assessment of myocardial perfu-
sion.
The assessment of resting perfusion defects using intra-
venous MCE in patients with prior AMI has been shown to
correlate well with regional activity measured using radio-
nuclide imaging (25,26), and other studies have demon-
strated the potential of this technique to detect reversible
perfusion defects using dobutamine and dipyridamole stress
(27).
Study limitations. In this study, only triggering intervals of
1:1, 1:5 and 1:10 were used. It is possible that longer
triggering intervals may have further improved the detection
of viable myocardium. Also, although a semiquantitative
scoring system was used for contrast assessment, this gave
only three points on the reperfusion curve, and it meant that
we were unable to differentiate between the possibilities of
normal flow and small vessel sludging with a patent epicar-
dial vessel. Quantitative analysis of contrast opacification
might have improved the separation of groups even further.
However, our objective was to determine whether there was
any clinical value in the use of unprocessed MCE for the
assessment of tissue viability early after AMI. Ideally, for a
study of this type, a continuous infusion of contrast should
have been used to ensure constant contrast concentrations in
the blood throughout each examination. However, we used
a slow bolus injection, which was continued until all images
had been acquired in that view and, thus, were able to
maintain relatively stable contrast concentrations during the
image acquisition period. Myocardial contrast echocardiog-
raphy is prone to artefact and attenuation. This is a
particular problem in the basal inferoposterior segments,
which may limit the interpretation of MCE in these
segments. This is perhaps the reason why we saw a higher
false negative rate in patients with inferior AMI. However,
as we have demonstrated, these artefacts can often be
overcome with attention to detail and the use of nonstand-
ard views.
Conclusions. This study demonstrates that intravenous
triggered MCE can be used to assess myocardial viability as
early as three days after AMI. Furthermore, using delayed
MCE significantly improves the diagnostic power for the
prediction of akinetic myocardium that is likely to recover.
Specifically, if no contrast is seen in a given segment when
delayed MCE is used, it is strongly predictive of a lack of
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functional recovery. Thus, MCE can be used for bedside
diagnosis of viability of dysfunctional myocardium early
after AMI.
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